We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

135 hedge funds and large institutions have $362M invested in Surmodics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 50 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.22% more ownership

Funds ownership: 82.99%85.21% (+2.2%)

0% more funds holding

Funds holding: 135135 (0)

0% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 18

0% less capital invested

Capital invested by funds: $362M → $362M (-$398K)

24% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 50

56% less call options, than puts

Call options by funds: $3.06M | Put options by funds: $6.91M

Holders
135
Holders Change
Holders Change %
0%
% of All Funds
1.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
38
Reduced
50
Closed
18
Calls
$3.06M
Puts
$6.91M
Net Calls
-$3.84M
Net Calls Change
-$4.16M

SRDX Hedge Fund Activity: Q2 2025 in Review

135 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2025, worth a combined $362M — down 0.11% from $362M a quarter earlier.

Fund positioning in SRDX was balanced in Q2 2025: 18 funds opened new positions, 18 closed out, 38 added to existing stakes and 50 trimmed.

The largest buyer was Readystate Asset Management, opening a new position worth an estimated $12.5M. The largest seller was Disciplined Growth Investors, cutting an estimated $2.95M.

  • 135 institutional investors held Surmodics (SRDX) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $362M of Surmodics stock for Q2 2025, down 0.11% quarter-over-quarter.
  • 18 funds opened new Surmodics positions in Q2 2025 and 18 closed out, a net change of 0 holders.
  • The largest Surmodics buyer in Q2 2025 was Readystate Asset Management, an estimated $12.5M added.
  • The largest Surmodics seller in Q2 2025 was Disciplined Growth Investors, an estimated $2.95M sold.

Based on aggregated 13F filings for Q2 2025.